Journal of Cancer Biomoleculars and Therapeutics

Announcements

Important Notice: Change of Publisher

2026-01-08

Current Issue

Vol. 3 No. 2 (2026): Journal of Cancer Biomoleculars and Therapeutics

Published: 2026-04-08

Articles

CRISPR-Cas9 in Precision Oncology: Unraveling Resistance Mechanisms and Redefining Molecular Targeted Cancer Therapy

Muhammad Osama, Ayesha Ghafoor, Toheed Fatima, Muhammad Shaharyar, Khadija Javed, Zainab Bibi, Bisma, Farwa Shafique, Maryam Jameel

1-12
- PDF
Zongertinib in HER2-Mutant Advanced/Metastatic Solid Tumors: A Narrative Review and Future Prospectives

Faiza Fatima, Muhammad Taimur Ahmed, Mariam Akmal, Maryum Ahmed, Zachariya Aftab, Ansa Ali, Aeliya Mirza

13-24
- PDF

View All Issues

About the journal

Journal of Cancer Biomoleculars and Therapeutics (JCBT, EISSN: 3060-8856) is an international, peer-reviewed, open access journal on clinical and experimental research of cancer published quarterly online by ETERNO PRESS SDN. BHD.

Open Access: This journal operates under a "gold" Open Access model, providing free access to all readers. The Article Processing Charges (APC) for all article types (research, review, case reports) is $50, and the content will be published under a CC BY license. JCBT offers full or partial fee waivers for eligible articles from low- and middle-income economies. For specific APC policies, please refer to the Open Access.
Rapid Publication: Manuscripts are peer-reviewed and a first decision is provided to authors approximately 21 days after submission; acceptance to publication is undertaken in 14 days.
Recognition of Reviewers: Reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in JCBT, in appreciation of the work done.